Friday, 26 August 2016

Global Naloxone Hydrochloride Dihydrate Market Strategies, Service and Forecasts to 2021

This report provides detailed analysis of worldwide markets for Naloxone Hydrochloride Dihydrate provides extensive market forecasts (2016-2021) by region/country and subsectors.

It covers the key technological and market trends in the Naloxone Hydrochloride Dihydrate market and further lays out an analysis of the factors influencing the supply/demand for Naloxone Hydrochloride Dihydrate, and the opportunities/challenges faced by industry participants.

It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Naloxone hydrochloride (including CAS#: 51481-60-8 and CAS#: 357-08-4) is a specific, competitive opioid antagonist that acts at opioid receptors with agonist or mixed agonist-antagonist activity.

Naloxone, the active component of naloxone hydrochloride dihydrate, is a potent antagonist at mu-opioid receptors and produces opioid withdrawal effects in individuals physically dependent on full opioids.

In conjunction with calcium salts, naloxone has been proposed to participate in control of calcium turnover and the pain and functional activity of endocrine glands, by means of the down regulation and desensitization of opioid receptor and protein kinase C stimulation. Naloxone is studied in addiction research and alcoholism research.

The role of naloxone and other opioids on apoptosis in several human cancer cell lines has been probed. Naloxone (10-100 M) has been used to study proliferation and neurogenesis in cultured rat adult hippocampal progenitors.

8 Naloxone has also been utilized to modulate the NMDA receptor activation capability of the opioid receptor agonist DAMGO.

Global Naloxone Hydrochloride Dihydrate Market has been prepared based on the synthesis, analysis, and interpretation of information about the global Naloxone Hydrochloride Dihydrate market collected from specialized sources.

The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players.

The major players in the global Naloxone Hydrochloride Dihydrate market are Macfarlan Smith, Sanofi, Organon, Mallinckrodt, Sun Pharmaceutica, Siegfried, Hebei Aoxing Group, Gansu Puan, China National Pharmaceutical, Chengdu Tiantaishan, Shandong Xinhua, Easton Pharmaceutical, Gaobo Jingbang, Sinopharm A-Think, Shanxi Pudepharma.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Naloxone Hydrochloride Dihydrate industry has been provided.

Download Sample Request:

Table of Contents:

Part 1. Scope of Report
   1.1 Research Methodology
   1.2 Geographic Scope
   1.3 Years Considered

Part 2. Introduction
   2.1 Key Findings
   2.2 Value Chain Analysis
      2.2.2 Upstream
      2.2.3 Downstream

Part 3. Manufacture
   3.1 Manufacturing Process
   3.2 Issues and Trends

No comments:

Post a Comment